Protalix BioTherapeutics (PLX) Share-based Compensation Growth (3y) (2013 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | -34.72% |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | 4.80% |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 10.78% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 2.55% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 20.65% |
| 10 | Protalix BioTherapeutics | 164.49 Mn | 153.70 Mn | 29.62 Mn | -0.86% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -0.86% |
| Dec 31, 2025 | 10.74% |
| Sep 30, 2025 | 155.15% |
| Jun 30, 2025 | 34.63% |
| Mar 31, 2025 | -13.56% |
| Dec 31, 2024 | 16.09% |
| Sep 30, 2024 | 21.70% |
| Jun 30, 2024 | 38.58% |
| Mar 31, 2024 | 6.33% |
| Dec 31, 2023 | 10.47% |
| Sep 30, 2023 | -5.46% |
| Jun 30, 2023 | -3.03% |
| Mar 31, 2023 | 8.20% |
| Dec 31, 2022 | 31.69% |
| Sep 30, 2022 | -25.19% |
| Jun 30, 2022 | 8.24% |
| Mar 31, 2022 | 42.32% |
| Dec 31, 2021 | 0.00% |
| Sep 30, 2021 | 198.40% |
| Jun 30, 2021 | 199.20% |
| Mar 31, 2021 | 136.10% |
| Dec 31, 2020 | 180.39% |
| Sep 30, 2020 | 124.80% |
| Jun 30, 2020 | 40.53% |
| Mar 31, 2020 | 54.00% |
| Dec 31, 2019 | 1.91% |
| Sep 30, 2019 | -19.20% |
| Jun 30, 2019 | -15.29% |
| Mar 31, 2019 | -8.21% |
| Dec 31, 2018 | 2.96% |
| Sep 30, 2018 | -26.65% |
| Jun 30, 2018 | -70.65% |
| Mar 31, 2018 | -47.11% |
| Mar 31, 2017 | -43.95% |
| Dec 31, 2016 | -29.48% |
| Sep 30, 2016 | -44.51% |
| Jun 30, 2016 | -41.47% |
| Mar 31, 2016 | -35.02% |
| Dec 31, 2015 | -38.98% |
| Sep 30, 2015 | -51.46% |
| Jun 30, 2015 | -47.82% |
| Mar 31, 2015 | 48.10% |
| Mar 31, 2014 | 40.42% |
| Dec 31, 2013 | 17.21% |
| Sep 30, 2013 | 88.69% |
| Jun 30, 2013 | 95.71% |